Podocyte Interleukin‐23 Receptor Signaling in the Pathogenesis of Lupus Nephritis

Documenti analoghi

• Aberrant Glycosylation of IgG in Children With Active Lupus Nephritis Alters Podocyte Metabolism and Causes Podocyte Injury
  di: Rhea Bhargava, et al.
  Pubblicazione: (2025)
• Hypoxia Promotes the Expression of ADAM9 by Tubular Epithelial Cells, Which Enhances Transforming Growth Factor β1 Activation and Promotes Tissue Fibrosis in Patients With Lupus Nephritis
  di: Masataka Umeda, et al.
  Pubblicazione: (2024)
• ADAM9 Promotes Glycolysis in Th17 Cells and Autoimmunity Through Activation of IGF ‐1 Signaling
  di: Kohei Karino, et al.
  Pubblicazione: (2025)
• Efficacy and Safety of Sodium–Glucose Cotransporter 2 Inhibitors for the Primary Prevention of Cardiovascular, Renal Events, and Safety Outcomes in Patients With Systemic Lupus Erythematosus and Comorbid Type 2 Diabetes: A Population‐Based Target Trial Emulation
  di: Kevin Sheng‐Kai Ma, et al.
  Pubblicazione: (2024)
• Biomarkers of Lupus Nephritis Histopathology: Where Do We Stand?
  di: Valentina Querin, et al.
  Pubblicazione: (2026)